Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02230839 · ClinicalTrials.gov registry record · NA

Muscle Insulin Resistance in Aging (Mirage)

A NA study of Insulin Resistance and Sarcopenia, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT02230839: Active NA study of Insulin Resistance and Sarcopenia, sponsored by AdventHealth Translational Research Institute.

NCT02230839 is a NA study of Insulin Resistance and Sarcopenia that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 200 participants, below the 244-participant average among 120 other Insulin Resistance trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02230839, a NA study of Insulin Resistance and Sarcopenia, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to provide information regarding potential factors underlying metabolic dysfunction, insulin resistance, and loss of muscle mass in aging muscle.

Primary Outcome

A percutaneous muscle biopsy of the vastus lateralis will be obtained, and the intramyocellular lipids will be measured by high-performance liquid chromatography-tandem mass spectrometry.

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Energy Restriction-Induced Weight Loss

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2014-06
Est. Completion 2025-12
Phase NA

What the registry record for NCT02230839 still lists

NCT02230839 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 244-participant average among 120 other Insulin Resistance trials with a reported enrollment target (18% lower).

The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT02230839 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02230839 about?

NCT02230839 is a clinical study titled "Muscle Insulin Resistance in Aging (Mirage)". The purpose of this study is to provide information regarding potential factors underlying metabolic dysfunction, insulin resistance, and loss of muscle mass in aging muscle.

What is the current status of trial NCT02230839?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2014-06. Estimated completion is 2025-12.

What conditions does trial NCT02230839 study?

This clinical trial studies the following conditions: Insulin Resistance, Sarcopenia.

What interventions are being tested in trial NCT02230839?

The interventions under investigation include: Exercise (BEHAVIORAL), Energy Restriction-Induced Weight Loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT02230839?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02230839 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02230839's enrollment target sits among peer trials

200 11th of 120 higher than 110 of 120 other Insulin Resistance trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02230839, the US trial registry maintained by the National Library of Medicine. NCT02230839 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.